Heraeus: Platinum demand in the petroleum industry has been hit hard
On October 16, Hu Min, General Manager of Heraeus Precious Metals China, said that due to the new crown pneumonia epidemic this year, the demand for platinum in the petroleum industry has been hit hard and is expected to shrink by about 50% this year.
Platinum catalyst is a key active agent for crude oil reforming to produce high-octane gasoline. Petroleum catalysts accounted for about 7 tons of platinum demand last year, and it is expected that demand for petroleum platinum will shrink by more than 3 tons in 2020.
As the epidemic has not yet been brought under control and travel activities have dropped sharply, global oil demand is expected to drop by 8.4 million barrels per day to 91.6 million barrels per day in 2020. The decline in demand for petroleum products threatens the survival of refineries. The United States, Europe and Southeast Asia have seen reductions in refining capacity, and some refineries are facing the threat of closure. The closure of the refinery will allow platinum recovered from the old catalyst to enter the market again.
Therefore, Heraeus expects that the platinum market will continue to maintain a surplus, and the platinum released by the closure of refineries will further aggravate the market surplus, thereby increasing downward pressure on platinum prices.
2026-09-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
BASF and Heraeus Joint Venture in China Goes into Operation
-
Heraeus: Helping China towards the goal of 'double carbon'
-
China Eases July Fuel Export Curbs as Zhejiang Petrochemical Resumes Shipments
-
BASF Reports Modest Third Quarter Decline Amid Global Market Caution
-
Evonik Launches Advanced Gas-Phase Alumina Plant in Japan
-
Huafon Chemical Plans RMB 6.85 Billion Acquisition to Expand Its TPU and PU Resin Portfolio
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy
Recommend Reading
-
AstraZeneca’s Wainua Fails Phase III Heart Trial, Wiping Out About $27 Billion in Market Value
-
$2.43 Billion Deal: Olin Buys Huntsman
-
Kering and L'Oréal Form $4 Billion Strategic Alliance in Luxury Beauty and Wellness
-
Three-Phase Plan for 120,000 Tons! “TPU King” Zhuhai Makes Its Move—Covestro’s New Plant Signals Not Just Capacity Expansion but a Full-Scale Upgrade in the Asia-Pacific Market Battle
-
Biochem to Acquire BASF’s Global Glycinates Business
-
On July 13, China's propylene oxide market showed a significant upward trend
-
Upward Momentum Fades, Formic Acid Prices Return to Stable Operation
-
Geopolitical Supply Concerns on July 13 Boost Ethylene Glycol Prices Significantly in China
-
U.S.-Iran Conflict Reignites, International Crude Oil Surges Over 9% in a Single Day
-
Premium Global Chemical Sourcing Requests (10-14 Nov 2025)